Clinical Trial Update: Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating first-line treatment of advanced pancreatic cancer with albumin-bound paclitaxel and gemcitabine, with or without S-1, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Abraxane (albumin-bound paclitaxel) (paclitaxel protein-bound albumin)
• Gemzar (gemcitabine) (gemcitabine)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Pancreatic Adenocarcinoma | Phase 2 | Status: RECRUITING